Coenzymes & Antioxidants
Nicotinamide adenine dinucleotide
Also known as NAD+ · NAD
Last reviewed: 2026-11-19
Evidence status & limitations
Small human exposure studies mostly measure biomarkers and tolerability; precursor trials cannot be transferred to NAD+ itself.
Regulatory status
No FDA-approved human medicine for this exact identity was established in this review. Investigational research is not approval.
Status as of 2026-11-19. Regulations change. Check FDA.gov for current information.
WADA prohibited status: current list and contextKnown risks & open questions
Long-term safety and clinical outcome evidence for external NAD+ remain limited.
Key sources
Primary-reference and editorial check: November 19, 2026. Not an exhaustive clinical review; exact formulations and populations matter.
Related compounds
- Cyanocobalamin
Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications
- Glutathione
Same scientific class · A 3-amino-acid chain. · Early human trials